Aptorum Group, Qualigen Therapeutics, and Incannex Healthcare Ltd. are the 3 Penny Stocks to watch on July 17, 2025, based on TipRanks’ Penny Stock Screener tool. Penny stocks are defined as stocks that trade at or below $5 per share and have a market capitalization below $300 million.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
The Penny Stock Screener helps investors scan stocks based on numerous parameters, including Sector, Price Target Upside, Smart Score, Analyst Consensus, Dollar Volume, and Price Change.
We leveraged the tool to pick the top three penny stocks with the highest Dollar Volume as of the close on July 16, 2025. Simply put, Dollar Volume is the number of shares traded on a particular day multiplied by the day’s share price.
Aptorum Group (APM) – Aptorum is a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapeutics for neurology, infectious diseases, gastroenterology, oncology and other disease areas. On July 16, APM had a Dollar Volume of $381.03 million, while its stock price skyrocketed by 100%.
Yesterday, Aptorum announced that it has entered into a definitive merger agreement with DiamiR Biosciences, under which DiamiR Biosciences will retain its name and become a wholly owned subsidiary of Aptorum Group. The merger is expected to close in the fourth quarter of 2025, subject to shareholder and regulatory approvals. The combined company is expected to continue trading on the Nasdaq Stock Market upon the closing of the merger.
Qualigen Therapeutics (QLGN) – Qualigen is a clinical-stage biotechnology company focused on developing novel treatments for adult and pediatric patients with rare cancers. Yesterday, QLGN had a Dollar Volume of $189.07 million, accompanied by a stock price surge of more than 11%.
The stock rose yesterday on news that the company had received new patents covering 25 countries for its QN-302 drug. Qualigen in-licensed the G4 selective transcription inhibitor platform from University College London (UCL) in 2022. The new patents cover the product and its methods of manufacturing.
Incannex Healthcare Ltd. (IXHL) – Australia-based Incannex Healthcare is a clinical-stage biopharmaceutical company developing treatments for chronic conditions such as obstructive sleep apnea, rheumatoid arthritis, and generalized anxiety disorder. On Wednesday, IXHL had a Dollar Volume of $80.56 million, while its shares rose by about 14%.
There was no specific news about Incannex yesterday to justify its stock price rally.
To find more penny stocks like these, you can take a look at TipRanks’ Penny Stock Screener tool. It shows a list of all penny stocks, their price movement, and other vital data.